Agilon Health, Inc. (NYSE: AGL) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $2.0B. The Maz Rating grades it against the other companies in its sector.
Agilon Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $116.75, Agilon Health, Inc. trades at 0.3x sales and 7.0x book value. Over the last twelve months it generated about $6.0B of revenue and a net loss of $109M. It runs a gross margin of 2.8%, an operating margin of -1.8% and a net margin of -1.8%. It shows return on equity of -51.9%, return on invested capital of -31.6% and a free cash flow yield of -1.6%. On the balance sheet: a debt-to-equity ratio of 0.12 and a current ratio of 1.13. Over the past 52 weeks the share price ranged from $7.48 to $133.04, with a beta of 3.11.
Agilon Health, Inc. does not currently pay a dividend.
26 Wall Street analyst ratings cover the stock: 10 Buy, 14 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.